U.S. Patent and Trademark Office (PTO) NOTICE OF ALLOWANCE |
ISSUE DATE OF NOA: Jul 15, 2003
CHRISTINE M. BAKER MINTZ LEVIN COHN FERRIS GLOVSKY ET AL 1 FINANCIAL CTR BOSTON MA 02111-2621 |
ATTORNEY REFERENCE NUMBER 18217-031 [C |
** IMPORTANT INFORMATION: 6 MONTH DEADLINE ** Please note that both the "Statement of Use " and "Extension Request" have many legal requirements, including fees. These requirements are explained in the PTO booklet "Basic Facts About Trademarks", which can be obtained upon request at (703)308-9000. In addition, there are printed forms contained in this booklet (for "Statement of Use" and "Extension Requests") for your use. |
The following information should be reviewed for accuracy:
SERIAL NUMBER: | 76/306207 |
MARK: | OXIGENE THE VASCULAR TARGETING COMPANY |
OWNER: | OXIGENE, INC. |
321 Arsenal Street Watertown , MASSACHUSETTS 02472 |
Section 1(a): NO | Section 1(b): YES | Section 44(e): NO |
GOODS/SERVICES BY INTERNATIONAL CLASS
042 - | Cancer research; research and development of biopharmaceutical products, namely, vascular targeting agents and cancer therapies; and licensing of intellectual property in the field of biopharmaceutical compounds for vascular targeting agents and cancer therapies |
ALL OF THE GOODS/SERVICES IN EACH CLASS ARE LISTED
ADDITIONAL INFORMATION MAY BE PRESENT IN THE PTO RECORDS